1. MARKETS
  2. SECTOR : OTHERS
  3. INDUSTRY : OTHERS
  4. INHIBRX BIOSCIENCES INC.

Inhibrx Biosciences Inc.

XNAS: INXB

Watchlist

Portfolio

Share
Board Meeting
The next board meeting for Inhibrx Biosciences Inc. is on 28 May 2025 for the purpose of Inhibrx Biosciences Inc Annual General Meeting for 2024 See details


Insider Trading disclosures for Inhibrx Biosciences Inc.

The latest disclosure was made by David J. Matly in Inhibrx Biosciences Inc. where a trade of 50,000 Stock Option (right to buy) done was reported to US exchanges on April 1, 2025.

Insider trading is the trading of a company’s securities by individuals with access to confidential or material non-public information about the company. A company is required to report trading by corporate officers, directors, or other company members with significant access to privileged information to the Securities and Exchange Commission (SEC).

Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
David J. Matly President Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2025 50,000 50,000 - - Stock Option (right to buy)
Kelly D. Deck Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 01 Apr 2025 15,000 15,000 - - Stock Option (right to buy)
Jon Faiz Kayyem Director Gift of securities by or to the insider at price $ 0.00 per share. 27 Mar 2025 90,000 419,360 - 0 Common Stock
Jon Faiz Kayyem Director Gift of securities by or to the insider at price $ 0.00 per share. 16 Dec 2024 250,000 250,000 - 0 Common Stock
Jon Faiz Kayyem Director Gift of securities by or to the insider at price $ 0.00 per share. 16 Dec 2024 250,000 250,000 - 0 Common Stock
Jon Faiz Kayyem Director Gift of securities by or to the insider at price $ 0.00 per share. 16 Dec 2024 500,000 509,360 - 0 Common Stock
Jon Faiz Kayyem Director Gift of securities by or to the insider at price $ 0.00 per share. 06 Dec 2024 52,000 1,009,360 - 0 Common Stock
Jon Faiz Kayyem Director Purchase of securities on an exchange or from another person at price $ 14.19 per share. 19 Nov 2024 18,750 69,843 - 14.2 266,102 Common Stock
Jon Faiz Kayyem Director Purchase of securities on an exchange or from another person at price $ 14.23 per share. 19 Nov 2024 34,843 51,093 - 14.2 495,708 Common Stock
Jon Faiz Kayyem Director Purchase of securities on an exchange or from another person at price $ 14.19 per share. 19 Nov 2024 18,750 69,843 - 14.2 266,102 Common Stock
Jon Faiz Kayyem Director Purchase of securities on an exchange or from another person at price $ 14.23 per share. 19 Nov 2024 34,843 51,093 - 14.2 495,708 Common Stock
Kristiina Vuori Director Purchase of securities on an exchange or from another person at price $ 15.00 per share. 03 Oct 2024 6,667 20,443 - 15 100,005 Common Stock
Kristiina Vuori Director Purchase of securities on an exchange or from another person at price $ 15.07 per share. 10 Sep 2024 6,457 13,776 - 15.1 97,307 Common Stock
Kristiina Vuori Director Purchase of securities on an exchange or from another person at price $ 15.00 per share. 10 Sep 2024 179 7,319 - 15 2,685 Common Stock
Kristiina Vuori Director Purchase of securities on an exchange or from another person at price $ 14.00 per share. 29 Aug 2024 7,140 7,140 - 14 99,960 Common Stock
Kimberly J. Manhard Director Purchase of securities on an exchange or from another person at price $ 13.98 per share. 28 Aug 2024 10,000 10,000 - 14.0 139,800 Common Stock
Jon Faiz Kayyem Director Gift of securities by or to the insider at price $ 0.00 per share. 24 Jun 2024 10,000 16,250 - 0 Common Stock
Jon Faiz Kayyem Director Gift of securities by or to the insider at price $ 0.00 per share. 24 Jun 2024 89,050 1,061,360 - 0 Common Stock
Jon Faiz Kayyem Director Gift of securities by or to the insider at price $ 0.00 per share. 24 Jun 2024 10,000 16,250 - 0 Common Stock
Jon Faiz Kayyem Director Purchase of securities on an exchange or from another person at price $ 17.23 per share. 05 Jun 2024 49,284 1,142,145 - 17.2 849,163 Common Stock
Jon Faiz Kayyem Director Purchase of securities on an exchange or from another person at price $ 17.89 per share. 05 Jun 2024 8,265 1,150,410 - 17.9 147,861 Common Stock
Jon Faiz Kayyem Director Purchase of securities on an exchange or from another person at price $ 16.14 per share. 31 May 2024 70,193 876,268 - 16.1 1,132,915 Common Stock
Jon Faiz Kayyem Director Purchase of securities on an exchange or from another person at price $ 16.61 per share. 31 May 2024 46,792 923,060 - 16.6 777,215 Common Stock
Jon Faiz Kayyem Director Purchase of securities on an exchange or from another person at price $ 17.90 per share. 31 May 2024 80,738 1,003,798 - 17.9 1,445,210 Common Stock
Jon Faiz Kayyem Director Purchase of securities on an exchange or from another person at price $ 17.44 per share. 31 May 2024 65,337 1,069,135 - 17.4 1,139,477 Common Stock
Jon Faiz Kayyem Director Purchase of securities on an exchange or from another person at price $ 18.24 per share. 31 May 2024 23,726 1,092,861 - 18.2 432,762 Common Stock
Kristiina Vuori Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 May 2024 30,000 30,000 - - Stock Option (right to buy)
Kimberly J. Manhard Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 May 2024 30,000 30,000 - - Stock Option (right to buy)
Kelly D. Deck Chief Financial Officer Grant, award, or other acquisition of securities at price $ 0.00 per share. 30 May 2024 175,000 175,000 - - Stock Option (right to buy)
Brendan P. Eckelman Chief Scientific Officer 29 May 2024 40,000 40,000 - - Common Stock
Brendan P. Eckelman Chief Scientific Officer 29 May 2024 433,888 433,888 - - Common Stock
Jon Faiz Kayyem Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 May 2024 806,075 806,075 - - Common Stock
Jon Faiz Kayyem Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 May 2024 30,000 30,000 - - Stock Option (right to buy)
Jon Faiz Kayyem Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 May 2024 6,250 6,250 - - Common Stock
Jon Faiz Kayyem Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 29 May 2024 6,250 6,250 - - Common Stock
Brendan P. Eckelman Chief Scientific Officer 29 May 2024 175,000 175,000 - - Stock Option (right to buy)
Brendan P. Eckelman Chief Scientific Officer 29 May 2024 40,000 40,000 - - Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades disclosures
Screeners based on Insider Trading and SAST parameters